We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+15.27%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.3B
AUM Growth
+$1.38B
Cap. Flow
-$440M
Cap. Flow %
-2.54%
Top 10 Hldgs %
32.07%
Holding
728
New
61
Increased
216
Reduced
343
Closed
55

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$85M
2
ABT icon
Abbott
ABT
+$53.8M
3
EXC icon
Exelon
EXC
+$46.6M
4
BSX icon
Boston Scientific
BSX
+$42.6M
5
ABBV icon
AbbVie
ABBV
+$32.4M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$80.5M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$54.5M
3
CRWD icon
CrowdStrike
CRWD
+$45.7M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.6M
5
MRK icon
Merck
MRK
+$39.3M

Sector Composition

Rank Sector Weight
1 Technology 36.26%
2 Healthcare 22.78%
3 Financials 10.33%
4 Consumer Discretionary 7.75%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMB icon
426
Kimberly-Clark
KMB
$37.8B
$2.91M 0.02%
22,594
-14,411
-39% -$1.95M
EQT icon
427
EQT Corp
EQT
$32.1B
$2.9M 0.02%
49,809
+6,614
+15% +$357K
CVNA icon
428
Carvana
CVNA
$46.5B
$2.88M 0.02%
42,705
+3,420
+9% +$188K
CCL icon
429
Carnival Corporation Ltd
CCL
$38.5B
$2.82M 0.02%
100,345
-1,848
-2% -$39.5K
MNST icon
430
Monster Beverage
MNST
$96.4B
$2.8M 0.02%
44,673
+5,108
+13% +$312K
TREX icon
431
Trex
TREX
$4.62B
$2.78M 0.02%
51,062
IT icon
432
Gartner
IT
$10.5B
$2.76M 0.02%
6,833
+123
+2% +$51.5K
AVB icon
433
AvalonBay Communities
AVB
$27.2B
$2.76M 0.02%
13,568
-2,705
-17% -$553K
CPRT icon
434
Copart
CPRT
$28.4B
$2.75M 0.02%
55,981
+7,443
+15% +$417K
NBP
435
NovaBridge Biosciences American Depositary Shares
NBP
$201M
$2.74M 0.02%
+1,132,563
New +$1.54M
F icon
436
Ford
F
$59.4B
$2.74M 0.02%
252,530
-132,470
-34% -$1.35M
PRAX icon
437
Praxis Precision Medicines
PRAX
$8.25B
$2.68M 0.02%
63,671
ACGL icon
438
Arch Capital
ACGL
$37.3B
$2.67M 0.02%
29,372
-1,255
-4% -$116K
GERN icon
439
Geron
GERN
$924M
$2.67M 0.02%
1,895,892
-118
-0% -$167
CTSH icon
440
Cognizant
CTSH
$23.9B
$2.66M 0.02%
34,087
-7,382
-18% -$566K
HES
441
DELISTED
Hess
HES
$2.65M 0.02%
19,157
+1,528
+9% +$206K
ODFL icon
442
Old Dominion Freight Line
ODFL
$47.5B
$2.65M 0.02%
16,340
+1,234
+8% +$197K
ITRI icon
443
Itron
ITRI
$4.44B
$2.63M 0.02%
+19,974
New +$2.26M
CTVA icon
444
Corteva
CTVA
$59.4B
$2.62M 0.02%
35,209
+279
+0.8% +$18.6K
SBAC icon
445
SBA Communications
SBAC
$19B
$2.61M 0.02%
11,128
-6,455
-37% -$1.48M
HUBS icon
446
HubSpot
HUBS
$12.1B
$2.6M 0.02%
4,676
+651
+16% +$381K
EQR icon
447
Equity Residential
EQR
$25.5B
$2.58M 0.01%
38,216
-3,280
-8% -$225K
LPLA icon
448
LPL Financial
LPLA
$27.3B
$2.58M 0.01%
6,871
+533
+8% +$187K
RJF icon
449
Raymond James Financial
RJF
$34.1B
$2.57M 0.01%
16,778
-424
-2% -$60.7K
NTRS icon
450
Northern Trust
NTRS
$22.2B
$2.54M 0.01%
20,038
-4,072
-17% -$416K

Similar funds

Candriam SCA's Q2 2025 Portfolio in Review

As of Q2 2025, Candriam SCA held 728 positions worth $17.3B, up 8.6% from $16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q2 2025 filing shows 61 new, 216 increased, 343 reduced and 55 closed positions. Its largest new stake was Tapestry: 260,834 shares worth $22.9M. The largest sale was Tesla, an estimated $80.5M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2025 buy was Tapestry: 260,834 shares worth $22.9M.
  • Candriam SCA added most to Broadcom in Q2 2025, an estimated $85M increase.
  • Candriam SCA's biggest Q2 2025 reduction was Tesla, cutting an estimated $80.5M.
  • Candriam SCA fully exited Banco Macro in Q2 2025, selling an estimated $17.6M.
  • Candriam SCA's ten largest holdings make up 32% of its $17.3B portfolio in Q2 2025.
  • Candriam SCA opened 61 new positions and closed 55 in Q2 2025.
  • Candriam SCA's portfolio value rose 8.6% quarter-over-quarter to $17.3B.

Based on Candriam SCA's 13F filing for Q2 2025, filed 8 Aug 2025.